Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation.
about
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@en
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@nl
type
label
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@en
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@nl
prefLabel
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@en
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@nl
P2093
P2860
P356
P1476
Immobilized doxorubicin increa ...... nent C3b against inactivation.
@en
P2093
M Panneerselvam
R Bredehorst
P2860
P304
P356
10.1073/PNAS.83.23.9144
P407
P577
1986-12-01T00:00:00Z